Clarification: Financial Markets-Stocks story
Posted June 01, 2016 7:00 am
NEW YORK (AP) - In a story May 31, The Associated Press described the drug Zinbryta as belonging to Biogen. The drug is being developed and promoted by Biogen and AbbVie.